FDA and CDC lift J&J vaccine pause (updated)

Apr. 23, 2021 7:27 PM ETJohnson & Johnson (JNJ)JNJBy: Jonathan Block, SA News Editor64 Comments
  • The FDA and CDC on Friday evening lifted a pause in administering the Johnson & Johnson (NYSE:JNJ) COVID-19 vaccine.
  • The decision came only a couple of hours after the CDC's Advisory Committee on Immunization practices voted to recommend resumption of the vaccine, though with a warning on rare cases of blood clots.
  • The FDA has updated the patient fact sheet for the vaccine to reflect the risk.
  • In a statement, J&J Chief Scientific Officer Paul Stoffels said that the company will continue to work with the FDA, CDC and other international regulatory bodies "to ensure this very rare event can be identified early and treated effectively."

Recommended For You

Comments (64)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.